no image available Dickens & Co. "Hope Amidst the Storm: Unraveling the Outcomes of HER2-Positive Early-Stage Breast Cancer in the Trastuzumab Era" "A population-based study of Canadian patients sheds light on the impact of trastuzumab on survival rates and treatment outcomes" Price: 25.00€